Clinical Trials Logo

Upper Respiratory Infection clinical trials

View clinical trials related to Upper Respiratory Infection.

Filter by:

NCT ID: NCT02110732 Completed - Acute Otitis Media Clinical Trials

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of oral administration of probiotic Lactobacillus rhamnosus GG in middle ear and adenoid tonsil.

NCT ID: NCT01916031 Completed - Clinical trials for Upper Respiratory Infection

Appropriate Care of URI (ACURI): Early Head Start

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to comparatively assess the effectiveness of a tailored educational intervention to improve health literacy levels regarding upper respiratory infections (URIs) and to decrease pediatric emergency department (PED) visits, among Latino households in Early Head Start.

NCT ID: NCT01657643 Completed - Clinical trials for Upper Respiratory Infection

Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections

Start date: January 2011
Phase: N/A
Study type: Interventional

The main purpose of the study is to find out if probiotics (healthy bacteria found in yogurt) can improve the health-related quality of life (HRQL) during upper respiratory infections (like the common cold) in college students living in residence hall on-campus at Framingham State University (Framingham, MA) who are randomized to receive a probiotic or placebo candy daily for 12 weeks. HRQL is a subjective measure, defined as the aspects of quality of life (i.e., one's satisfaction with their life) that related specifically to a person's health (for example, ability to carry out normal daily activities). The investigators hypothesize that HRQL during URIs will be significantly higher in the probiotic groups compared to the placebo group. The proposed study will also seek to address the following secondary objectives: missed school and work days due to a upper respiratory infection.

NCT ID: NCT01588249 Terminated - Cough Clinical Trials

A Novel Formulation of Pasteurized Maple Cough Syrup Compared With Placebo on Nocturnal Cough and Sleep Quality in Infants With Upper Respiratory Infection

Start date: April 2012
Phase: N/A
Study type: Interventional

Cough is a frequent symptom in children and infants and is one of the most common reasons parents visit a healthcare provider for their child. The US Food and Drug Administration has issued a warning that over-the-counter cough and cold medicines including antihistamines, decongestants, anti-tussives, and expectorants should not be administered to children younger than 2 years of age due not only to lack of proven efficacy, but also because of important safety concerns. A product that has been used in alternative medicine for cough is maple syrup. Although no studies have formally evaluated the use of maple syrup for nocturnal cough associated with URI, the demulcent effect of maple syrup may provide some relief from cough in children. A novel formulation of pasteurized maple cough syrup, when compared to placebo, should provide superior relief on nocturnal cough and the sleep difficulty associated with URI in children under 12 months and sleep difficulty of their parent/caregiver.

NCT ID: NCT01168778 Completed - Clinical trials for Upper Respiratory Infection

Improving Communication During Pediatric Visits for Acute Respiratory Illness

Start date: September 2007
Phase: N/A
Study type: Interventional

The excessive use of outpatient antibiotics in the pediatric population has contributed to the rapid development of resistance in many strains of Streptococcus pneumoniae. Research has shown that community-based interventions may have a modest impact on reducing the injudicious use of antibiotics in children. However, since the actual prescribing of antibiotics is done by physicians and research has shown that physician-parent communication patterns during pediatric visits for acute respiratory tract infections (ARTI) strongly influence antibiotic prescription rate, it is crucial to develop effective interventions aimed specifically at them. The overall goal of this study is to improve physician-parent communication patterns during visits for pediatric ARTI and, ultimately, to decrease rates of antibiotic prescribing for these illnesses in children.

NCT ID: NCT00796315 Completed - Allergic Rhinitis Clinical Trials

Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children

Start date: December 2008
Phase: Phase 1
Study type: Interventional

The primary goal of this study is to characterize the pharmacokinetics of doxylamine succinate in children ages 2 to < 18 years. Once characterized, these pediatric pharmacokinetic data will be pooled with historical adult PK data from other studies to assess whether the existing Over-the-Counter (OTC)doses provide comparable systemic drug exposure as that associated with efficacy in adults.

NCT ID: NCT00694421 Completed - Clinical trials for Upper Respiratory Infection

Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2

Start date: January 2008
Phase: N/A
Study type: Observational

This study will test the hypothesis that constitutionally poorer Eustachian tube function predisposes to middle-ear pathology during a viral upper respiratory infection.

NCT ID: NCT00642681 Completed - Diabetes Mellitus Clinical Trials

Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

Start date: December 2007
Phase: Phase 2
Study type: Observational

Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge

NCT ID: NCT00405509 Completed - Common Cold Clinical Trials

The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years

Start date: October 2006
Phase: N/A
Study type: Observational

This study examines the cold processes of children aged 6 to less than 14. Children will be seen by the study staff 6 days in a row during the course of their naturally-acquired colds. Nasal secretions will be examined for chemicals that the body creates during a cold. Skin cells will be collected by brushing the inside of the child's cheek with a small brush. The cells will be examined for genes that may hold control the creation of these chemicals.

NCT ID: NCT00259831 Completed - Clinical trials for Upper Respiratory Infection

Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults

Start date: December 2005
Phase: Phase 3
Study type: Interventional

The purpose of the Study is to determine the prophylactic effects of CVT-E002 treatment for upper respiratory tract infections in healthy adult employees working with residents in continuing care facilities. It is hypothesized that the use of CVT-E002 will effectively reduce the incidence, severity and duration of upper respiratory infections among the participants when compared to placebo.